We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Jul 2019 to Jul 2024
BUDAPEST--Hungary's largest firm MOL Nyrt. (MOL.BU) is set to spend $1 billion in acquisitions with an upstream focus this year, its chief executive said Thursday.
MOL, a regional oil and gas explorer and refiner, is aiming to boost its oil and gas production in Iraq's Kurdistan region, in the North Sea in Europe, as well as in Croatia and Hungary, József Molnár said at the company's annual general meeting.
MOL expects daily hydrocarbon output at 105,000 to 110,000 barrels in 2015 compared with between 91,000 and 96,000 this year, Mr. Molnár said, but organic growth and the planned acquisitions could boost this to 130,000 barrels a day in five years.
At the AGM, the shareholders approved to pay a dividend of 60 billion forints ($269 million) from the firm's 2013 profit. Dividend per share will rise to HUF590 from HUF462 last year.
Shares in MOL was trading up 0.8% at HUF13,240 late morning on Thursday.
Write to Veronika Gulyas at veronika.gulyas@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
